Results 231 to 240 of about 103,945 (310)

Integration of eQTL and GEO Datasets to Identify Genes Associated with Breast Ductal Carcinoma In Situ. [PDF]

Curr Issues Mol Biol
Mo CQ, Xie RW, Li WW, Zhong MJ, Li YY, Lin JY, Zhang JS, Zheng SK, Lin W, Kong LJ, Xu SW, Chen XJ.   +11 more
europepmc   +1 more source

Avascular Necrosis and Minimal Trauma Fractures in Telomere Biology Disorders

Clinical Genetics, Volume 109, Issue 2, Page 286-293, February 2026.
Avascular Necrosis (AVN) and Minimal Trauma Fractures (MTF) cause significant morbidity in people with Telomere Biology Disorders (TBDs). They occur more frequently in young patients and in those with autosomal recessive (AR) or X‐linked recessive (XLR) than in autosomal dominant (AD) genotypes.
Arman M. Niknafs, Neelam Giri, Marena R. Niewisch, Sharon A. Savage   +3 more
wiley   +1 more source

Postoperative radiotherapy for ductal carcinoma in situ: survival prediction and clinical decision support using a nomogram-based approach. [PDF]

Sci Rep
Wang Y, Zhang J, Wu Y, Liang Y.
europepmc   +1 more source

Ductal Carcinoma in Situ of the Breast

Cambridge International Law Journal, 2018
C. Mariotti
semanticscholar   +1 more source

To VAE or not to VAE: outcomes of radial scars/complex sclerosing lesions and papillary lesions without atypia in the King's College Hospital breast service (2017–2023)

Histopathology, Volume 88, Issue 3, Page 583-590, February 2026.
Radial scars/complex sclerosing lesions (RS/CSL) without atypia have a low upgrade rate (1%) and could possibly be monitored radiologically, thus avoiding excision. Papillary lesions without atypia have a higher upgrade rate (4%) and should continue to undergo vacuum excision until we better understand these heterogeneous lesions.
Amy Llewellyn, Adam Brown, Juliet Morel, Kalnisha Naidoo   +3 more
wiley   +1 more source

Epigenetic regulation of breast ductal carcinoma in situ by miR-217 through DNMT1 and Hedgehog-GLI pathway. [PDF]

J Cell Commun Signal
Wang Z, Wu L, Lai S, Guo S, Pu C, Zhang L, Li X.   +6 more
europepmc   +1 more source

Ductal carcinoma in situ

, 2022
openaire   +1 more source

RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.

Journal of Clinical Oncology, 2015
B. McCormick, K. Winter, C. Hudis, H. Kuerer, E. Rakovitch, Barbara L. Smith, N. Sneige, J. Moughan, A. Shah, I. Germain, A. Hartford, A. Rashtian, E. Walker, A. Yuen, E. Strom, Jeannette L Wilcox, L. Vallow, W. Small, A. Pu, K. Kerlin, J. White   +20 more
semanticscholar   +1 more source

Invasive ductal carcinoma and ductal carcinoma in situ

, 2014
openaire   +1 more source

Ductal Carcinoma In Situ of the Breast: An Analysis of 12 Years of Experience From a Tertiary Center. [PDF]

Cureus
Tepetam H, Hanilce MM, Dursun CU, Gedik D, Karabulut Gul S.   +4 more
europepmc   +1 more source